What you need to know
- 3.17(ii)Societal decisions about stem cellAn undifferentiated cell that can divide and differentiate into specialised cell types. in medical therapies.
- 3.17(i)Stem-cell properties and potency underpin possible uses.
These notes explain biological mechanisms and ethical reasoning. They do not recommend treatment or claim that all proposed stem-cell applications are established therapies.
By the end, you should be able to…
- Link therapeutic potential to stem-cell properties.
- Compare sources and practical limitations.
- Develop a balanced, evidence-based ethical argument.
Build your understanding
From potential to an effective treatment
stem cellAn undifferentiated cell that can divide and differentiate into specialised cell types. can self-renew and produce specialised descendants, suggesting ways to replace damaged cells or restore tissue function. However, generating a cell type in a dish is not equivalent to producing a safe, effective treatment.
Cells must have the right identity and function, survive in the appropriate location, integrate with the tissue and remain controlled. Risks can include unwanted cell types, uncontrolled proliferation, infection during processing and immune responses. Which risks matter depends on the cells and procedure; no source removes all uncertainty.
Compare the sources
Tissue stem cells can be used without obtaining cells from an embryo, and using a person’s own cells can reduce some compatibility problems. Their developmental range and availability may be limited, and they may retain disease-associated genetic changes.
Embryonic stem cells have broad pluripotentDescribes a stem cell that can differentiate into almost any cell type in the body, but not placenta cells. potential and can be expanded in culture. Conventional derivation from the inner cell mass involves loss of the embryo’s ability to develop, raising ethical concerns. Donor-derived cells can also face immune compatibility problems.
Induced pluripotent stem cells avoid deriving the cell line from an embryo and can be made from a person’s specialised cells. Reprogramming and culture still require careful quality checks; genetic abnormalities, unwanted differentiationThe process by which a cell becomes specialised, because some genes are switched on and others are switched off. and uncontrolled growth remain concerns. “From your own cells” is not a guarantee of safety.
Evidence and values answer different questions
Scientific evidence can investigate function, risks, benefits and alternatives. Ethical decisions also consider consent, the moral status of embryos, potential relief of suffering, fair access and the use of limited resources. Evidence informs these discussions but does not by itself determine which values society should prioritise.
Present arguments accurately without claiming that every person in a religious, cultural or professional group holds one view. Consent must be informed and voluntary. Decisions should distinguish established uses from research proposals and marketing claims; oversight and transparent evidence matter.
Evaluate a fictional proposal
A research team proposes testing a new cell preparation after a laboratory study shows improved function in damaged tissue. Before human use, ask whether the cells are consistently identified, whether effects are replicated in suitable models, how uncontrolled growth is assessed and what adverse outcomes were monitored.
For a clinical study, compare a clearly defined outcome with an appropriate control, use adequate follow-up and report harms as well as benefits. A dramatic individual testimonial lacks a counterfactual: improvement might have occurred for other reasons. The ethical case should consider expected benefit, uncertainty, participant consent and reasonable alternatives.
Make your reasoning visible
Connect benefit to mechanism
Explain how differentiationThe process by which a cell becomes specialised, because some genes are switched on and others are switched off. into a needed cell type could restore a function, rather than saying stem cellAn undifferentiated cell that can divide and differentiate into specialised cell types. “cure anything”.
Balance with relevant evidence
Pair potential benefits with biological limitations and ethical considerations. Do not merely list “for” and “against”.
Avoid universal claims
A successful use of one stem-cell type does not validate every treatment labelled “stem cell”.
Avoid this misconception
The claim: A patient’s own stem cells are always safe.
The correction: Compatibility can improve, but genetic changes, contamination, inappropriate differentiation and uncontrolled proliferation can still matter.
Check your understanding
Try each question before opening the suggested answer.
Practice question
Retrieval and explanation · suggested answer
Explain one advantage and one limitation of using a patient-derived cell line.
Show suggested answer
It may reduce immune incompatibility, but can retain disease-associated variants and still needs checks for appropriate function and safe growth.
Practice question
Retrieval and explanation · suggested answer
Why does showing a desired protein in cultured cells not prove a therapy will work?
Show suggested answer
The cells also need correct function, survival, integration and controlled growth in the relevant tissue; protein detection alone does not establish these or clinical benefit.
Practice question
Retrieval and explanation · suggested answer
Give a scientific question and an ethical question for an embryonic stem-cell proposal.
Show suggested answer
Scientific: do the cells restore function without unacceptable adverse effects? Ethical: how should potential benefit be weighed against concerns about embryo use, consent and access?
Take the idea further
Apply the same specification knowledge to an unfamiliar problem. Any extra assumptions are supplied in the question.
Stretch question
Two groups accept the same evidence of likely benefit and risk but disagree about embryo use. Must one group misunderstand the science?
Show a hint
Separate factual disagreement from different priorities.
Explore the reasoning
No. They may assign different moral weight to embryo status and relief of suffering. Clarify shared evidence and uncertainty, then explain the value judgement rather than implying science alone resolves it.
Recall this lesson
Lesson recall questions
Question 1 of 5: Define a stem cell.
Stem cells and therapies
Practice question
Retrieval and explanation · suggested answer
Define a stem cell.
Try this from memory first.
Put your biology to work
Explore where these ideas appear in the world. Enrichment, not extra required recall.
An established use: blood-cell production
3C · Using Stem CellsThe NHS describes blood stem-cell transplantation as a way to replace damaged blood-forming cells. This provides a concrete example of stem-cell biology in healthcare. For a transplant, donor…Specification 3.17(ii)Read & use the scienceClose article
Why this matters
The NHS describes blood stem-cell transplantation as a way to replace damaged blood-forming cells. This provides a concrete example of stem-cell biology in healthcare. For a transplant, donor cells must be compatible enough to reduce harmful immune responses, and patients may need preparation before receiving them. That clinical complexity matters when a headline claims stem cells cure a disease. Blood-forming stem cells have a proven role for selected conditions, yet a different tissue would require different cells and evidence. Ethical decisions include likely benefit, risk and the source of the cells. A strong answer distinguishes an established use from experimental proposals instead of treating all stem-cell treatments as equivalent.
Back to the specification
Pearson Edexcel IAL Biology · Issue 2, February 2021 · Unit 2, pp. 21–24. The application extends beyond required recall.
- 3.17(ii) be able to discuss the ways in which society uses scientific knowledge to make decisions about the use of stem cells in medical therapies
Use the science
Why does this example not establish that the same cells can rebuild every organ?
Explore a possible response
Blood-forming stem cells have a restricted developmental range. Evidence for one cell type and clinical use cannot simply be transferred to unrelated tissues.
Explore the source
An experimental retinal-cell patch
3C · Using Stem CellsThe US National Eye Institute describes a small early-stage trial of retinal pigment epithelium cells made from a patient’s reprogrammed cells. Researchers are testing whether a patch can…Specification 3.17(ii) · 3.18Read & use the scienceClose article
Why this matters
The US National Eye Institute describes a small early-stage trial of retinal pigment epithelium cells made from a patient’s reprogrammed cells. Researchers are testing whether a patch can be delivered safely and followed over years; the trial is not proof of a standard cure for age-related macular degeneration. The case shows why differentiation into a particular cell type matters more than the broad label stem cell. It also shows why a medical decision uses staged evidence. Students should distinguish the cells’ laboratory origin, the specialised product being transplanted, and the clinical outcome that has yet to be established. Headlines about a vision cure would jump beyond what this early trial is designed to establish.
Back to the specification
Pearson Edexcel IAL Biology · Issue 2, February 2021 · Unit 2, pp. 21–24. The application extends beyond required recall.
- 3.17(ii) be able to discuss the ways in which society uses scientific knowledge to make decisions about the use of stem cells in medical therapies
- 3.18 understand how cells become specialised through differential gene expression, producing active mRNA, leading to the synthesis of proteins which, in turn, control cell processes or determine cell structure in animals and plants
Use the science
What evidence would be needed beyond producing retinal cells in a dish before claiming the patch is an effective treatment?
Explore a possible response
Safety after implantation, survival and correct function of the cells, and improved patient outcomes compared with an appropriate comparator would all be needed.
Explore the source
- Clinical trial highlight: stem cell transplants for dry AMDNational Eye Institute